ATHENS, OH -- (MARKET WIRE) -- December 12, 2006 -- Privately held Diagnostic HYBRIDS, Inc. (DHI) announced today that it and Immunicon Corporation (NASDAQ: IMMC) of Huntingdon Valley, PA signed a definitive license, development, supply and distribution agreement to develop and commercialize products in the field of clinical virology diagnostics, starting with a panel of multiplex respiratory virus and sexually transmitted infection assays. Financial and other details of the agreement were not disclosed.
